JohnCharlesRuckdeschelMD

PubMed

• 2 citations
  Unstructured Data Are Superior to Structured Data for Eliciting Quantitative Smoking History From the Electronic Health Record.
  John C Ruckdeschel, Mark Riley, Sriram Parsatharathy, Rajesh Chamarthi, Chakethraman Rajagopal
  JCO Clinical Cancer Informatics. 2023-02-01
• 5 citations
  Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials.
  Arsalan Hamid, Markus S Anker, John C Ruckdeschel, Muhammad Shahzeb Khan, Arsal Tharwani
  Journal of the American Heart Association. 2022-08-02
• 4 citations
  Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer
  Bryan J. Schneider, Gregory P. Kalemkerian, Shirish M. Gadgeel, Manuel Valdivieso, Deborah Hackstock
  Clinical Lung Cancer. 2017-05-01

Journal Articles

• Implementing a Comprehensive Lung Cancer Screening Program in an Integrated Hospital System: Outcomes After Initial Round of Screening  
  Miller AT, Krueger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev D, J Amer Coll Radiol, 1/1/2016
• Use of post-treatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?  
  Hahn EE, Tang T, Lee JS, Munoz-Plaza C, Adesina O, Shen E, Rowley B, Maeda JL, Mosen DM, Mosen DM, Ruckdeschel JC, Gould MK, Cancer, 1/9/2015
• Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers  
  Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRusso P, Hayes DF, Hussain M, Ruckdeschel JC, Fendrick MA, Trask PC, Ronis DL, Kershaw T, Psycho-Oncology, 1/1/2013
• A Randomized, Double Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Persons with Resected Stage I Non Small Cell Lung Cancer...  
  Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston M, Goodman G, Clamon G, Okawara G, Marks R, Frechette E, McCaskill-Stevens W, Lippma..., J Clin Oncol, 1/1/2013
• Granulomatous Solitary Pulmonary Nodule  
  Turner JT, Khoury JD, Ruckdeschel JC, J Bronchol Intervent Pulmonol, 1/1/2011
• Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in stage III non-small cell lung cancer (NSCLC) patients  
  Gadgeel SW, Ruckdeschel JC, Patel, BB, Wozniak A, Konski A, Valdivieso M, Hackstock D, Chen W, Belzer K, Marquette L, Turrisi A, J Thorac Oncol, 1/1/2011
• Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kitpositive, extensive-stage small-cell lung cancer  
  Schneider BJ, Kalemkerian GP, Ramnath N, Kraut MJ, Wozniak AJ, Worden FP, Ruckdeschel JC, Zhang X, Chen W, Gadgeel SM, Clin Lung Cancer, 1/1/2010
• Chronic obstructive lung diseases and risk of non-small cell lung cancer  
  Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, Ruckdeschel JC, Gadgeel S, Soubani A, J Thorac Oncol, 1/1/2009
• Studying the Process of Clinical Communication: Issues of Context, Concepts and Research Directions  
  Albrecht TL, Eggly SS, Penner LA, Cline RJW, Ruckdeschel JC, J Health Commun, 1/1/2009
• Oncologists� recommendation of clinical trial participation to patients  
  Eggly, S., Albrecht, T.L., Harper, F.W.K., Foster, T.,., Franks, M.M., Ruckdeschel, JC, Patient Education and Counseling, 1/1/2008
• Influence of clinical communication on patients� decision making on participation in clinical trials  
  Albrecht, T.L., Eggly S.S., Gleason M.E., Harper F.W., Foster T.S., Petereson A.M., Orom H, Penner L.A., Ruckdeschel JC, J Clin Oncol, 1/1/2008
• Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancer  
  Gadgeel SM, Wozniak A, Ruckdeschel JC, Heilbrun LK, Venkatramanamoorthy R, Chaplen RA, Kraut MJ and Kalemkerian GP, J Thor Oncol, 1/1/2008
• Treatment of non-small cell lung cancer-stage IIIA; ACCP evidence-based clinical practice guidelines (2nd edition)  
  Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW, Chest, 1/1/2007
• Parent�s interpersonal distance and touch behavior and child pain and distress  
  Paterson A., Cline R., Foster T, Jones E, Penner L, Parrott R,. Keller C, Naughton M, Taub J, Ruckdeschel JC, Albrecht T, Journal of Nonverbal Behavior, 1/1/2007
• Camera-related behaviors during video recorded medical interactions  
  Penner L, Orom H, Franks M, Albrecht T, Foster T, Ruckdeschel JC, Journal of Nonverbal Behavior, 1/1/2007
• Patients� Internet use for cancer information and socioeconomic status as co-advantages in oncologist-patient communication  
  Cline RJW, Penner LA, Harper FWK, Foster TS, Ruckdeschel JC, Albrecht T, Journal of Oncology Practice, 1/1/2007
• Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) and celecoxib a cyclooxygenase-2 (COX-2) inhibitor, in patients w...  
  Gadgeel SM, Ruckdeschel JC, Heath EL, Heilbrun LK, Venkatramanamoorthy R, Wozniak A, J Thorac Oncol, 1/1/2007
• Discussing 'bad news' in the outpatient oncology clinic: rethinking current communication guidelines  
  Eggly S, Penner L, Albrecht TL, Cline RJW, Foster T, Naughton M, Peterson A, Ruckdeschel JC, J Clin Oncol, 1/1/2006
• Second line chemotherapy for non-small cell lung cancer  
  Ruckdeschel JC, Chest, 1/1/2006
• Transdisciplinary studies of surgical oncology trial accrual: A National Institute of Health/ National Cancer Institute Roadmap-affiliated project update  
  Albrecht TL, Kuerer H, Ruckdeschel JC, Mendez J, Harper F, American College of Surgeons Oncology Group, Cancer, 1/1/2006
• Information seeking during �bad news� oncology interactions: Question asking by patients and their companions  
  Eggly S, Penner LA, Greene M, Harper FW, Ruckdeschel JC, Albrecht TL, Soc Sci Med, 1/1/2006
• A portable, unobtrusive device for video recording clinical interactions  
  Albrecht TL, Ruckdeschel JC, Ray FL 3rd,Pethe BJ, Riddle DL, Strohm J, Penner LA, CoovertMD, Quinn G, Blanchard CG, Behav Res Methods, 1/1/2005
• The problem of lung cancer as a paradigm-keynote address  
  Ruckdeschel JC, Ethnicity Dis, 1/1/2005
• Early detection and treatment of spinal cord compression  
  Ruckdeschel JC, Oncology, 1/1/2005
• Risk of lung cancer among white and black relatives of individuals with early lung cancer  
  Cote ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG, JAMA, 1/1/2005
• Join now to see all

Books/Book Chapters

• The Art and Science of Oncology 
  Chapter: At the Core of Oncology 
  Page 33 - 44Ruckdeschel JCAspatore Books, Boston, MA2007
• Challenges to physician communication about treatment options to patients 
  Helft PR, Albrecht TL, Back A, Ruckdeschel JCASCO Educational Book Alexandria: American Society of Clinical Oncology2006
• Clinical Oncology 
  Chapter: Lung cancer 
  Page 1649 - 1743Ruckdeschel JCEditors: Abeloff M, Armitage J, and Niederhuber J.Churchill-Livingstone, Philadelphia, PA2004
• Update in the management of lung cancer 
  Ruckdeschel JCEditors: Ruckdeschel JC (Guest editor).RogersMIS, New York, NY2004
• Myths and facts about lung cancer. What You Need to Know 
  Ruckdeschel JCPRR Publishers, Melville, NY2004
• Cancer Medicine 
  Chapter: Respiratory complications of cancer and its treatment 
  Ruckdeschel JC, Greene J, Sommers KE, Fields KKEditors: Kufe DW, Holland JF, Frei E.BC Decker, Hamilton, ON; Lewiston, NY2003
• Communication in the management of health and illness 
  Chapter: The mediating role of communication in cancer treatment decision making 
  Albrecht TA, Blanchard CG, Ruckdeschel JC, Coovert MAEditors: Brashers D, Goldsmith D, and Lammers L.Lawrence Erlbaum & Associates, Manwah, NJ2003
• Myths and facts about lung cancer: What You Need to Know 
  Ruckdeschel JCPRR Publishers, Melville, NY2002
• Lung cancer: Principles and practice of palliative care and supportive oncology 
  Chapter: Management of pleural and pericardial effusions 
  Ruckdeschel JC, Robinson LEditors: Berger, Portenoy, Weissman.Lippincott, Williams & Wilkins, Philadelphia, PA2001
• Current Cancer Therapeutics 
  Chapter: Malignant effusions of the chest 
  Ruckdeschel JC, Jablons DEditors: Kirkwood JM, Lotze MT, Yasko JM.2001
• Oncology therapeutics: a quick reference guide 
  Chapter: Intrapleural therapy 
  Ruckdeschel JCEditors: Ratain MJ, Tempero M, Skosey C.WB Saunders, Philadelphia, PA2000
• Cancer and the family 
  Chapter: Patient family communication with physicians 
  Page 477 - 495Blanchard C, Albrecht T, Ruckdeschel JCEditors: Bader, Cooper, DeNour.John Wiley & Sons, Ltd, West Sussex, England2000
• Myths and facts about lung cancer: What You Need to Know 
  Ruckdeschel JCPRR Publishers, Melville, NY1999
• Clinical Oncology 
  Chapter: Spinal cord compression 
  Page 811 - 819Ruckdeschel JCEditors: Abeloff M, Armitage J, Lichter A, Niederhuber J.Churchill Livingstone, New York, NYEdition 2nd,1999
• Swallowing Intervention in Oncology 
  Chapter: Lung cancer 
  Page 117 - 133Mackey CS, Ruckdeschel JCEditors: Sullivan P, Guilford AM.Singular Publishing, San Diego, CA1999
• Advances in lung cancer management: 1997 Miami Valley hospital lung conference 
  Yanes B, Bonomi PD, Curran Jr WJ, Ginsberg RJ, Khuri FR, Ruckdeschel JC, Weiland JEBristol Myers Squibb1998
• Current clinical trials in thoracic oncology - what the chest physician needs to know 
  Chapter: The early detection of second primary lung cancers by sputum immunostaining 
  Tockman M, Ruckdeschel JC, Mulshine JEditors: Jett J.1998
• Chemotherapy for lung cancer: new agents with significant benefit 
  Ruckdeschel JC1998
• Commentary and review of presentations on lung cancer 
  Ruckdeschel JC, Aisner J, Evans W, Gandara D, Green M, Holmes EC, Ihde DC, Johnson DH, Sause WT, Wagner Jr HBristol Myers Squibb1998
• Taxanes in lung cancer therapy 
  Chapter: Single agent paclitaxel as second-line chemotherapy for resistant, metastatic non-small cell lung cancer 
  Garland LL, Ruckdeschel JC, Wagner Jr H, Williams Jr C, Shaw G, Antonia S, Heise M, Hilstro J, Cantor AEditors: Johnson, Klastersky.Marcel Dekker, Inc., New York, NY1998
• Lung cancer: principles and practice of supportive oncology 
  Chapter: Management of pleural and pericardial effusions 
  Page 327 - 352Robinson L, Ruckdeschel JCEditors: Berger, Portenoy, Weissman.JB Lippincott, Philadelphia, PA1998
• Current clinical trials in thoracic oncology - what the chest physician needs to know 
  Chapter: A prospective randomized trial of bleomycin vs doxycycline vs talc for the intrapleural treatment of malignant pleural effusions 
  Ruckdeschel JCEditors: Jett J.1997
• Current approaches to managing patients with small cell lung cancer 
  Ruckdeschel JC, Aisner J, Ettinger D, Jett J, Wagner HSmith Kline Beecham1997
• New approaches in the treatment of stage IV non-small cell lung cancer 
  Bonomi P, Ruckdeschel JCBristol Myers Squibb1997
• Comprehensive geriatric oncology 
  Chapter: Lung cancer 
  Page 613 - 630Antonia S, Robinson LA, Ruckdeschel JC, Wagner HEditors: Balducci, Lyman, Ersher.Harwood Academic Publishers, London, England1997
• Join now to see all

Abstracts/Posters

• Use of advanced imaging for staging of early breast cancer in two integrated health care systems: Adherence with a Choosing Wisely Recommendation
  Hahn EE, Tang T, Lee JS, Munoz-Plaza C, Adesina O, Shen E, Rowley B, Maeda JL, Mosen DM, Ruckdeschel JC, Gould M, J Clin Oncol, 1/1/2015
• First-Year Patient Outcomes in a Comprehensive Lung Cancer Screening Program
  Miller AT, Krueger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev D, American Thoracic Society, 1/1/2015
• Patient Characteristics and Symptoms at Time of Enrollment in First-Year Comprehensive Lung Cancer Screening Program
  Miller AT, Krueger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev D, American Thoracic Society, 1/1/2015
• Radiographic Incidental Findings Identified on Low-Dose Computed Tomography in a First-Year Comprehensive Lung Cancer Screening Program
  Miller AT, Krueger P, Conner K, Robertson T, Rowley B, Sause W, Ruckdeschel JC, Blagev D, American Thoracic Society, 1/1/2015
• Establishment of a Comprehensive Lung Cancer Screening Program: First Year Successes and Problems
  Ruckdeschel JC, Miller AT, Krueger P, Conner K, Robertson T, Rowley B, Sause,W, Blagev D, J Thor Oncol, 1/1/2015
• Second Primary Lung Cancers: Analysis of E5597 Selenium Chemoprevention Study
  Pillai NR, Lee SJ, Karp DD, Aisner S, Ruckdeschel JC, Ramalingam S, and Khuri FR, J Clin Oncol, 1/1/2014
• Evolution of quality to value added care in a large healthcare organization
  Sause WT, Rees WV, Ruckdeschel JC, Jones CW, Rowley BD, Pena K, J Clin Oncol, 1/1/2013
• The impact of screening mammography in women 40-49 years of age as a function of tumor biology
  Ruckdeschel JC, Rees WV, Parkinson BT, Belnap T, Rowley BD, Pena K, J Clin Oncol, 1/1/2013
• Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma (MPM)
  Krug LM, Wozniak AJ, Kindler HL, Feld R, Koczywas M, Morero JL, Rodriguez CP, Ross HJ, Bauman JE, Orlov SV, Ruckdeschel JC, Mita AC, Fein L, Fernandez C, Hall R, Kawab..., ASCO Annual Meeting; International Mesothelioma Research Group, 1/1/2012
• Oncology quality improvement as a cornerstone of the transition to accountable care
  Ruckdeschel JC, Sause WT, Belnap T, Jones C, Rowley, B, J Clin Oncol, 1/1/2012
• Building success in quality improvement: An analysis of what barriers hinder and what catalysts promote the widespread adoption of quality improvement initiatives
  Sause WT, Ruckdeschel JC, Belnap TW, Jones C, Rowley BD, J Clin Oncol, 1/1/2012
• The role, use, and nuances of clinical data systems in oncology quality improvement
  Belnap TW, Sause WT, Rowley,BD, Jones C, Ruckdeschel JC, J Clin Oncol, 1/1/2012
• Cebiranib, a VEGF receptor 1,2 and 3 inhibitor, and pemetrexed in patiens (pts) with recurrent nonsmall cell lung cancer (NSCLC)
  Gadgeel SM, Ruckdeschel JC, Wozniak AJ, Chen W, Hackstock D, Galasso C, Burger A, Ivy SP, LoRusso P, Edelman MJ, ASCO Annual Meeting, 1/1/2011
• Pemetrexed and cisplatin with concurrent thoracic radiation therapy (TRT) followed by Docetaxel in stage III non small cell lung cancer (NSCLC) patients
  Gadgeel SM, Ruckdeschel JC, Wozniak A, Patel B, Heilbrun LK, Chen W, Venkat R, Chaplen R, Turrisi A, J Clin Oncol, 1/1/2008
• The influence of patient and companion cure expectations on treatment decisions
  Gleason ME, Harper FW, Eggly S, Ruckdeschel JC, Albrecht TL, J Clin Oncol, 1/1/2008
• Information seeking by patients and companions during cancer clinical interactions
  Eggly S, Harper F, Penner L, Foster T, Austin T, Ruckdeschel J, Albrecht T, Psycho-Oncology, 1/1/2008
• Patient/companion information seeking during offers of clinical trials
  Eggly S, Harper F, Penner L, Foster T, Rana J, Osborn D, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2007
• Expectations about cure, physician-patient communication, and treatment decision-making in cancer patients
  Harper F, Gleason M, Eggly S, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2007
• A pahse II study of XL647 in non small cell lung cancer (NSCLC) patients enriched for presence of EGFR mutations
  Rizvi N, Kris, M, Miller V, Azzoli C,Krug L, Bekele S,Chaplen R, Ruckdeschel J, Gadgeel S, J Thor Oncol, 1/1/2007
• Progress Report: Eastern Cooperative Oncology Group (ECOG) E5597, an intergroup phase III randomized trial of selenium supplementation in resected stage I non small ce...
  Karp DD, Lee S, Shae G, Johnson D, Kucuk O, Clamon G, Marks R, Johnston M, Okawara G, Ruckdeschel J, J Thor Oncol, 1/1/2007
• Dispositional and affective correlates of treatment related pain among pedicatric cancer patients
  Penner L, Cline R, Jones E, Taub J, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2006
• Indirect support: Effects of multiple caregivers on nonverbal immediacy experienced by children during painful pediatric oncology procedures
  Penner L, Cline R, Foster T, Jones E, Penner Taub J, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2006
• Verbal combat: Risks of invalidating children�s experiences during painful oncology procedures
  Cline R, Jones E, Peterson A, Penner L, Taub J, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2006
• Frequency and context of oncologist� recommendations regarding clinical trials
  Eggly S, Franks M, Hendriks M, Figueroa M, Foster T, Ruckdeschel JC, Albrecht T, Annals of Behavioral Medicine, 1/1/2006
• Physician communication and patient intention to accrue to cancer clinical trials
  Franks M, Eggly S, Figueroa M, Hendriks M, Foster T, Ruckdeschel JC, Albrecht T, Cancer Epidemiology, Biomarkers & Prevention, 1/1/2005
• Join now to see all

Other

• Locally advanced lung cancer - controversies in management 
  Ruckdeschel JC, Wagner H, Robinson L, ASCO Educational Book
  1/1/1996
• MPE II: recent findings in the clinical management of malignant pleural effusions 
  Ruckdeschel JC, Moores D, LP Communications
  New York, NY - 1/1/1990
• Non-small cell lung cancer: a multimodality approach to treatment 
  Ruckdeschel JC, Moores D, LP Communications
  New York, NY - 1/1/1989
• Malignant pleural effusions: diagnosis and management 
  Ruckdeschel JC, Moores D, LP Communications
  New York, NY - 1/1/1988
• Lung cancer - mediguide to oncology 
  Ruckdeschel JC
  1/1/1981
• Join now to see all